{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:19Z","timestamp":1789726399581,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jiac.2025.102763","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:07:13Z","timestamp":1750849633000},"page":"102763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe drug eruption induced by teicoplanin, complicated by hemophagocytic syndrome: A case report and brief literature review"],"prefix":"10.1016","volume":"31","author":[{"given":"Hiroyuki","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Kitaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syotaro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Amitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Nagamizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Chikumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jiac.2025.102763_bib1","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jiac.2025.102763_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13256-019-2295-1","article-title":"Lamotrigine-induced hemophagocytic lymphohistiocytosis with Takotsubo cardiomyopathy: a case report","volume":"13","author":"Zhou","year":"2019","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jiac.2025.102763_bib3","article-title":"Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review","author":"Yang","year":"2020","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jiac.2025.102763_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.18176\/jiaci.0904","article-title":"Drug-induced hypersensitivity syndrome with hemophagocytic lymphohistiocytosis related to piperacillin-tazobactam: a case report","volume":"33","author":"Shen","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"8","key":"10.1016\/j.jiac.2025.102763_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.5649\/jjphcs.33.710","article-title":"Performance of software in predicting teicoplanin serum trough concentrations using two sets of pupulation phamacokinetics parameters","volume":"33","author":"Suzuki","year":"2007","journal-title":"Jpn J Pharmaceut Health Care Sci"},{"issue":"3","key":"10.1016\/j.jiac.2025.102763_bib6","first-page":"189","article-title":"Guidelines for the management of drug-induced hypersensitivity syndrome 2023","volume":"52","author":"Mizukawa","year":"2025","journal-title":"J Dematol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102763_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.jiac.2025.102763_bib8","first-page":"592","article-title":"Drug-induced hemophagocytosis","volume":"112","author":"Olivier","year":"2022","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.jiac.2025.102763_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1345\/aph.1H633","article-title":"Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin","volume":"41","author":"Hsiao","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.jiac.2025.102763_bib10","first-page":"1231","article-title":"Thrombocytopenia associated with teicoplanin use: a retrospective observational study","volume":"50","author":"Reem","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.jiac.2025.102763_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(98)00025-9","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"10","author":"Wilson","year":"1998","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.jiac.2025.102763_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","article-title":"[management of drug reaction with eosinophilia and systemic symptoms (DRESS)]","volume":"137","author":"Descamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"issue":"9927","key":"10.1016\/j.jiac.2025.102763_bib13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jiac.2025.102763_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/2229-5151.152349","article-title":"Severe hemophagocytic lymphohistiocytosis as a complication of drug-induced hypersensitivity syndrome","volume":"5","author":"Gauchan","year":"2015","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"1","key":"10.1016\/j.jiac.2025.102763_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D328157062","article-title":"Early onset drug-induced hypersensitivity syndrome with lymphopenia, hepatitis, and normal eosinophils induced by BRAF\/MEK inhibitor after immune checkpoint inhibitor therapy","volume":"28","author":"Buhle","year":"2022","journal-title":"Dermatol Online J"},{"issue":"12","key":"10.1016\/j.jiac.2025.102763_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2022-251255","article-title":"Haemophagocytic lymphohistiocytosis (HLH) in an adult following treatment with trimethoprim\/sulfamethoxazole","volume":"15","author":"Zimilover","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.jiac.2025.102763_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.reval.2019.09.010","article-title":"Dress syndrome : ph\u00e9notype cutan\u00e9 et atteinte visc\u00e9rale (\u00e9tude r\u00e9trospective de 62 cas)","volume":"60","author":"Kettani","year":"2020","journal-title":"Rev Fr Allergol"},{"issue":"3","key":"10.1016\/j.jiac.2025.102763_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030704","article-title":"\"Heart in DRESS\": cardiac manifestations, treatment and outcome of patients with drug reaction with eosinophilia and systemic symptoms syndrome: a systematic review","volume":"11","author":"Radovanovic","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jiac.2025.102763_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jiac.2025.102763_bib20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.jiac.2025.102763_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4253\/wjge.v4.i8.376","article-title":"Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis","volume":"4","author":"Li","year":"2012","journal-title":"World J Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.jiac.2025.102763_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaip.2013.04.001","article-title":"Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis","volume":"1","author":"Matthieu","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.jiac.2025.102763_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/apm.12694","article-title":"Erdheim-chester disease with unusual clinicopathological features complicated by DRESS syndrome, disseminated cytomegalovirus infection and hemophagocytic lymphohistiocytosis","volume":"125","author":"Gaspar","year":"2017","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.jiac.2025.102763_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.245.55","article-title":"Onset of hemophagocytic lymphohistiocytosis during piperacillin-tazobactam therapy in three children with acute focal bacterial nephritis","volume":"245","author":"Miyabayashi","year":"2018","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1016\/j.jiac.2025.102763_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5021\/ad.2018.30.1.71","article-title":"Drug reaction with eosinophilia and systemic symptoms associated with reactivation of epstein-barr virus nd\/or cytomegalovirus leading to hemophagocytic syndrome in one of two patients","volume":"30","author":"Liang","year":"2018","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.jiac.2025.102763_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2500\/aap.2017.38.4042","article-title":"A 28-year-old woman with fever, rash, and pancytopenia","volume":"38","author":"Ochoa","year":"2017","journal-title":"Allergy Asthma Proc"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:16:58Z","timestamp":1752711418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1341321X25001606"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102763","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe drug eruption induced by teicoplanin, complicated by hemophagocytic syndrome: A case report and brief literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102763"}}